This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

TIDES Europe: Oligonucleotide and Peptide Therapeutics
12 - 14 Nov 2024
Hamburg Congress CentreHamburg, Germany

ST Pharm

Profile

ST Pharm is a top-tier CDMO with an integrated technology platform supporting clinical- and commercial-scale production of next-generation therapeutic oligonucleotides, mRNA vaccines, and mRNA therapeutics. Our nucleic acid platform includes process development, analytical development, and manufacturing services that are enhanced by the supply of critical raw materials such as nucleotides, phosphoramidites, and capping reagents, as well as leading RNA delivery solutions including lipid nanoparticles. At ST Pharm, we are wholly committed to advancing life-saving nucleic acid medicines for patients around the world.

We're bringing you

  • Application of PAT for Process Understanding and Control Strategy during Development and Manufacturing of Oligonucleotides

    13:25
  • An Alternative Approach to Make Amidite Blocks and Full-Length Oligonucleotide Products via Newly Developed Liquid Phase Oligonucleotide Synthesis

    08:55